Drug details
Atelvia (risedronate sodium delayed-release tablets)
type of Bisphosphonate Derivatives, Calcium Metabolism Modifiers
Atelvia (risedronate sodium) Delayed Release Tablets is a bisphosphonate used to treat osteoporosis in postmenopausal women.
The drug is often used to treat Osteoporosis .
This drug may have the following side effects:
- headache
- nausea
- diarrhea
- vomiting
- constipation
- muscle pain
- back pain
- joint pain
- flu symptoms
- stomach pain or upset
The following drugs are related to Atelvia, either as a replacement or used together:
- Tymlos (abaloparatide injection)
- Activella (estradiol, norethindrone acetate)
- Fosamax (alendronate sodium)
- Fosamax Plus D (alendronate sodium and cholecalciferol)
- Binosto (alendronate sodium effervescent tablets)
- Aredia (pamidronate disodium)
- Boniva (ibandronate sodium)
- Boniva Injection (ibandronate sodium injection)
- Miacalcin (calcitonin-salmon)
- Prempro, Premphase (conjugated estrogens, medroxyprogesterone acetate)
- Didronel (etidronate disodium)
- Estrace (estradiol)
- Estraderm (estradiol transdermal)
- Minivelle (estradiol transdermal system)
- Menest (estrogens)
- Evista (raloxifene)
- Forteo (teriparatide (rdna origin) injection)